MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹3,622 Cr | ₹3,020 Cr | ₹2,515 Cr | ₹1,902 Cr | ₹1,991 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹3,622 Cr |
| Mar2025 | ₹3,020 Cr |
| Mar2024 | ₹2,515 Cr |
| Mar2023 | ₹1,902 Cr |
| Mar2022 | ₹1,991 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,622 Cr | 19.93 | |
| Mar2025 | ₹3,020 Cr | 20.09 | |
| Mar2024 | ₹2,515 Cr | 32.24 | |
| Mar2023 | ₹1,902 Cr | -4.45 | |
| Mar2022 | ₹1,991 Cr | - | |
Compare Operating Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹98,830.9 Cr | 0.3% | -8.6% | -5.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.3% |
-8.6% |
-5.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses